A B-cell non-Hodgkin's lymphoma (B-NHL) cell line (Karpas 1106) with an unusual three-way translocation involving 18q21.3 has been derived from a patient with mediastinal lymphoblastic B-NHL. Although conventional cytogenetics showed a derivative 18q-identical to that seen in cases with t(l4;18)(q32.3;q21.3), no translocations of either chromosome 14 could be detected. Instead fluorescent in situ hybridization analysis using a chromosome-l8 paint showed that the segment 18q21.3-18qter had become sandwiched on a derivative chromosome X between segments Xqter-cXq28 and 13q12-qter, with the centromeric site of 18q21.3 subband juxtaposed to the X sequences. Pulsed-field DNA HROMOSOMAL translocation t( 14; 1 Q(q32.3; q2 1.3) was first identified in follicular B-cell non-Hodgkin's lymphoma (B-NHL) in 1976 by Fukuhara and colleagues.' Identical translocations were subsequently detected in about 30% of diffuse B-NHL' and rarely in acute leukemias of mature B cells3 and B-cell chronic lymphoid leukemias (B-CLL).4 Molecular cloning studies have shown that the t(14; 18)(q32.3;q21.3) translocation juxtaposes the BCL2 gene with the Ig JH segments.'" In B-NHL, more than 90% of breakpoints in the BCL2 gene cluster to two regions of the 3' portion of the gene, which are termed the major breakpoint region (mbr) and the minor cluster region (mcr).' A different breakpoint cluster region lying between the mbr and rncr may be preferentially involved in rare cases of B-CLL with t(14; 18)(932.3;q21.3).' In addition, BCL2 translocations involving the 5' region of the BCL2 within the variant cluster region (vcr) with the Ig light-chain genes have been observed preferentially in B-CLL, but also in follicular B-"L.' "' ' Translocations involving the mbr may be promoted by the presence of recombinogenic chi-like sequences within the rnbr." However, no such sequences have been shown in the rncr or vcr, and other mechanisms such as the ability to form Z-DNA have been proposed to explain the clustering of breakpoints to the vcr." Therefore, the different types of BCL2 translocations seen in the different subtypes of B-cell malignancy may represent the action of different pathogenic mechanisms.
A B-cell non-Hodgkin's lymphoma (B-NHL) cell line (Karpas 1106) with an unusual three-way translocation involving 18q21.3 has been derived from a patient with mediastinal lymphoblastic B-NHL. Although conventional cytogenetics showed a derivative 18q-identical to that seen in cases with t(l4;18)(q32.3;q21.3), no translocations of either chromosome 14 could be detected. Instead fluorescent in situ hybridization analysis using a chromosome-l8 paint showed that the segment 18q21.3-18qter had become sandwiched on a derivative chromosome X between segments Xqter-cXq28 and 13q12-qter, with the centromeric site of 18q21.3 subband juxtaposed to the X sequences. Pulsed-field DNA HROMOSOMAL translocation t( 14; 1 Q(q32.3; q2 1. 3) was first identified in follicular B-cell non-Hodgkin's lymphoma (B-NHL) in 1976 by Fukuhara and colleagues.' Identical translocations were subsequently detected in about 30% of diffuse B-NHL' and rarely in acute leukemias of mature B cells3 and B-cell chronic lymphoid leukemias (B-CLL).4 Molecular cloning studies have shown that the t(14; 18)(q32.3;q21.3) translocation juxtaposes the BCL2 gene with the Ig JH segments.'" In B-NHL, more than 90% of breakpoints in the BCL2 gene cluster to two regions of the 3' portion of the gene, which are termed the major breakpoint region (mbr) and the minor cluster region (mcr).' A different breakpoint cluster region lying between the mbr and rncr may be preferentially involved in rare cases of B-CLL with t(14; 18)(932.3;q21.3).' In addition, BCL2 translocations involving the 5' region of the BCL2 within the variant cluster region (vcr) with the Ig light-chain genes have been observed preferentially in B-CLL, but also in follicular B-"L.' "' ' Translocations involving the mbr may be promoted by the presence of recombinogenic chi-like sequences within the rnbr." However, no such sequences have been shown in the blots failed to detect rearrangement of the BCL2 gene. Conventional DNA blots using a variety of restriction digests and both 5' and 3' BCL2 and FVT l probes also failed to detect rearrangement in Karpas 1106. A rearranged fragment seen only in Hindlll digests with 5' BCLZ probes may represent a local microalteration, which is either a mutation or small deletion involving the Hindlll site as seen in other cases of B-NHL. Neither BCLZ RNA nor BCLZ protein expression were detected. These and other data suggest that genes at 18q21.3, other than BCLZ and M 1 , may be targets for translocation in certain subgroups of B-NHL. 0 1994 by The American Society of Hematology.
rncr or vcr, and other mechanisms such as the ability to form Z-DNA have been proposed to explain the clustering of breakpoints to the vcr." Therefore, the different types of BCL2 translocations seen in the different subtypes of B-cell malignancy may represent the action of different pathogenic mechanisms.
Recently, translocations involving 18q21.3 have been identified that appear to deregulate the expression of genes other than BCL2. A case of follicular B-NHL with t(2;8)(pl l;q21.3) was shown to involve the IgK locus with a gene termed FVTI on 18q21.3 that lies immediately telomeric of BCL2.I3 Another translocation, which again does not involve BCL2 directly, is the t( 11 ; 18)(q2 1 ; q21.3), seen in lymphocytic and mucosa-associated lymphoid tissue B-NHL.14"h The involvement of the MLL gene at chromosome 1 lq23 in a similar translocation (t( 1 1 ; 18)(q23; q2 1.3)) has also been described, although whether this case involved BCLZ was not reported." These data indicate that in certain specific subgroups of B-cell disease, genes at 18q21.3 other than BCL2 may be activated by translocations.
We report here the preliminary characterization of an unusual B-NHL cell line derived from a patient with mediastinal lymphoblastic B-NHL with chromosomal translocation involving 18q21.3, but with no rearrangement of the BCL2 gene and no BCL2 expression. Fluorescent in situ hybridization (FISH) analysis showed that the segment 18q21.3-qter had become sandwiched between fractions of chromosome X and 13. This cell line may allow the isolation of other genes at 18q21.3 of importance in the pathogenesis of some B-NHL.
MATERIALS AND METHODS

Patient Material, Cell Culture, and Cytogenetics
The cell line was derived from a 23-year-old lady with no significant previous medical history who presented in September 1983 with mediastinal lymphoblastic B-NHL. She was treated with intravenous combination chemotherapy (cyclophosphamide, hydroxydaunorubicin, vincristine, and prednisolone) and initially remitted, but relapsed in May 1984 with widespread disease. Despite further therapeutic attempts, she died 4 months later with progressive chemotherapy-resistant B-NHL including massive ascites, bilateral pleural effusions, and CNS disease. Cell lines were established from both pleural and ascitic effusions as previously described'* and have was performed assisted by computer-based image-analysis system been maintained in intermittent culture since October 1984. No pa-(Smartcapture, Digital Scientific, Cambridge, UK). The ISCN 1991 tient material exists to compare directly with this cell line, but the nomenclature was used to describe the abnormal chromosome cytogenetic pattern observed 48 hours after culturing has remained markers. constant. Cytogenetic analysis was performed as described." Briefly, cells were synchronized with ethidium bromide and harvested 24 and 28 hours after the initiation of culture and at intervals of 4 weeks thereafter, using routine methods. Chromosome preparations were 
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some preparations were made after the cells were treated with BrdU (20 mg/mL) for 17 hours followed by ethidium bromidelcolcemid incubation for the last 90 minutes before harvest. Before denaturing, chromosome preparations were treated in 2X saline sodium citrate (SSC) for 60 minutes at 37°C.
Chromosomal DNA was denatured in 70% formamidel2x SSC at 75°C for 2 to 4 minutes, then dehydrated. Probc (paint) DNA plus unlabeled Cot-l DNA (S mglmL; GlBCO RRL. Gaithersburg. MD) were denatured at 75°C for 10 minutes. allowed to prcanncal for 90 minutes at 37°C and laid onto prewarmed slides under sealed coverslips. The hybridization was performed at 42°C for 12 to IS hours.
After hybridization. the slides were washed three times on 2X SSC. SO% formamide at 42°C followed hy two washes in 2X SSC and once on 0. I X SSC at 42°C. Visualization of the hybridized probe was achieved after incubation with ( I ) S mglmL fluorescein isothiocyanate (FITC)-avidin DCS. (Vector Laboratories. Burlingame. CA).
(2) S mglmL biotinylated goat antiavidin (Vector) and (3) FITCavidin DCS. All incubations were at 37°C for 30 minutes. Three washes. each 3 minutes in length, were performed between layers using 4 x SSC, 0.05% Tween 20. Chromosomes were counterstained with DAPl dissolved in antifading solution (Citifluor, Canterbury, UK) at a final concentration of 80 mglmL. Images were captured with CCD Camera (Photometrics. Tuscon. AZ) aided by dedicated software (Smartcapture. Digital Scientific. Cambridge. UK). The Gbanded appearance of the counterstained chromosomes was obtained by image processing using the same program.
Inlmrtrtr~phenor?pirlR
Cell surface antigen expression was detected using monoclonal antibodies (MoAhs) and flow cytometry as described.'" Cytoplasmic RCL2 expression was assessed using a cocktail of RCL2 MoAbs" and both immunocytochemistry and flow cytometry after cell permeahilization."." Cell lines Karpas 422 and DoHH2, which both exhihit a RCL2 mbr-IgJ,, fusion gene were used as positive controls.'.'.'' As a negative control, the primary antibody was omitted.
For both cell surface and cytoplasmic BCL2 antigen.
-, no detectable expression.
DNA and RNA Studies
Conventional DNA blotting. Conventional DNA blotting was performed as described?6 High molecular-weight DNA from Karpas 1106 and normal peripheral blood mononuclear cells was digested to completion with the following restriction endonucleases: EcoRI, HindIII, BomHI, Psr I, BgEII, EcoRV, and Kpn I (Promega, Madison W .
Pulsed-jeld DNA blots (PFGE). Pulsed-field DNA blots were performed as described.*' DNA blocks were digested with restriction endonuclease Nor I which yields a 650-kb germline BCL2 fragment."
RNA studies. Nothern blots were peformed using poly (Af) mRNA as described." Quantitation of the amount of mRNA applied and assessment of mRNA integrity were assessed by probing with a glyceraldehyde-3-phosphate dehydrogenase cDNA probe.
DNA probes. All DNA probes were used as gel-purified inserts and were labeled with 3ZP-deoxycytidine triphosphate (dCTP) to a specific activity of 2 2 X lo9 disintegrations per minute (dpm)/pg DNA by the method of oligopriming. Derivation of the probes used in this study may be found in the following references: FVTI: probes for the FVTl locus were 1 4 0 CA, 7/61, and 35R6. Probe 140 CA is a 0.4-kb Kpn I FVTl 3' cDNA fragment, whereas 7/61 and 35R6 are genomic clones lying immediately 5' and 30 to 40 kb 5' of the FVTl gene, respectively. 7/61 is a 0.8-kb EcoRI-Xbu I fragment and 35R6 a 0.8-kb HindIII fragmentI3 (and R. Rimokh. personal communication, November 1993); 5' BCLZ: two genomic clones lying 5' of the BCL2 coding sequences were used: pHB 0.6, a 0.6-kb HindIII-BamHI fragment" and pXX1.9, a 1.9-kb Xho I f~agment.'~ Additionally, a 1.6-kb cDNA clone, pB16, encoding part of the first and second exons of BCLZ, was also used"; 3' BCLZ (mbr): clone pm-l, a genomic fragment spanning the mb3; 3' BCL2 (mcr): clone pm-2, a genomic fragment spanning the minor cluster region"; 3' BCL2 (mbr-mcr): clone pMW-I, a 1.3-kb EcoRI-HindlII genomic fragment lying between the mbr and met?* The relationship of these F W I and BCL.2 probes is shown in Fig 1. References for the derivation of immunoglobulin (Ig) probes may be found in reference 26.
RESULTS
Cytogenetic and FISH Studies
A mainline cell clone was seen in all analyzed cells of Karpas 1106P, which was found to have the following chromosomal constitution (Fig 2): 49,X,de1(2)(pl1.2~13.3) , der (3) t (2;3) (p13.3;p25.1), +i9(p), ins(l2;?) (q13.lq13.3), del (14)(q11.2q13.1), del (15)q11.2q15.3), der(l8) t (X;13; 18)(q28;q21.3;qlZ.I), -20, del(2O)(q13.1q13.3) x 2, der (X)t(X; 13; 18) (q28;q21.3;q12.1), +iX(p).
To confirm this, dual-color FISH analysis with a chromosome 18 (in green) and X (in red) paints was performed (Fig  3) . This showed that the 18q21.3-qter segment was retained in the genome as part of the der(X) marker, sandwiched between segments Xqter-c-Xq28 and 13q12.1-qter (Fig 3D,  inset) . The presence of material from chromosome X at the telomeric end of der(l8) marker (see Fig 3A) is suggestive of a two-step mechanism of marker formation. Firstly t(X; 18) (q28;q21.3) followed by rearrangement between the der(X) and 13. This interpretation is in agreement with the results of the dual-painting experiments with chromosome 18 and 13 (Fig 3B) as well as X and 13 (Fig 3C) .
Chromosomes 14, 15, and 20 were found to have a partially deleted long arm. FISH analysis with relevant chromosome paints showed the presence of only two signals, thus suggesting that these deletions were interstitial. Painting with chromosome 12 probe showed uniform signal on the der( 12) chromosome, and this finding suggests that the inserted rnaterial belongs to chromosome 12. The t(2;3) was also confirmed with dual-color FISH chromosome painting.
Irnmunophenotypic Analysis
Both Karpas 1106A and 1106P had the phenotype of mature, class-switched IgG expressing B-cells as shown in Table l. There were no differences between the 1106A and P sublines. BCLZ expression was sought on three separate occasions in two laboratories by both flow cytometry and immunocytochemistry; no BCL2 expression was detected under conditions when both Karpas 422 and DoHH2 exhibited strong staining (Fig 4) .
DNA and RNA Studies
Rearrangements of both BCL2 and FVTl were sought in K q a s 1106. Results are summarized in Table 2 . In pulsedfield blocks digested with Not I, no BCL2 rearrangements could be detected using 3' BCLZ probe pMWl (data not shown). To confirm these data, and to extend the area analyzed, rearrangements in Karpas 1106 were sought using both BCL2 and FVTI probes in a wide variety of restriction digests by conventional DNA blot. No rearrangements were detected using 3' BCL2 and FVTI probes. Additionally, no rearrangements were detected using the 5' BCL2 probes except in HindIII digests (Fig 5) . The size of the rearranged HindIII fragment is consistent with a local microalteration at the 5' end of the BCL2 gene of one allele in the vicinity of the 5' HindIII site {Fig 1) resulting in the loss of that Hindnl site. Furthermore, these data indicate that the cytogenetically observed breakpoint at 18q21.3 fell outside both BCL2 and FVTI loci.
Studies with probes from the IG loci showed that both Karpas 1106A and 1106P sublines had identical biallelic IgJH rearrangements, indicative of a common clonal origin. Both alleles of IgClc were deleted, with biallelic IgCh re- No BCL2 RNA expression could be detected in Northern blots using 2 p,g of poly(A') RNA (Fig 6) .
DISCUSSION
The cell line Karpas I106 is of interest for two reasons. Firstly, although it was thought initially that BCL2 expression was a specific marker of the t(14; 18)(q32.3;q21.3) translocation, it has become clear that expression of this gene is, in fact, widespread, particularly in tissues characterized by programmed cell death or apopto~is.~ Most follicular and diffuse B-NHL and B-CLL express abundant BCLZ irrespective of whether they carry the t( 14; 18)(q32.3;q21.3) or Also, levels of BCLZ comparable with those seen not.?2.33-37 
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Probe pB 1 G - SU-DULS, in which one allele of BCL2 has been disrupted in a three-way translocation with MYC and lgJl+3' Other B-NHL lines that do not express BCL2 (eg, SU-DHL9) do not exhibit I8q2 I .3 translocations."" Our examination of other B-NHL lines that have 18q21.3 translocations but lack BCL2 rearrangement on DNA blot has shown abundant BCL2 expression in all three cases (M.J.S. Dyer, unpublished observations, December 1993). In Karpas 1106, it is possible that microalterations (either mutations or small deletions) at the S' end of the BCL2 gene (as detected by the rearrangement seen in Hind111 digests alone) may have inactivated the promoter of one allele, whereas the other promoter may be physiologically repressed. Such microalterations in the 5' region of the BCL2 gene have been previously reported both in B-NHL and in fresh patient In one case of follicular B-NHL, it was shown that these alterations reflect small deletions of the S' region of BCLZ.".' Similar deletions have been observed in the B-NHL cell line SU-DHL6; these deletions involved the major sites of initiation of BCL2 tran~cription.~' Secondly, despite lacking BCL2 expression, Karpas 1106 nevertheless has a translocation involving 18q2 I .3, although this does not appear to involve the BCL2 gene directly. These and other data""' suggest that genes at I8q21.3, other than BCL2, may have a role in the pathogenesis of certain subsets of B-NHL. Therefore, the Karpas 1106 cell line may allow the study of mechanisms of B-cell neoplasia independent of BCL2 expression.
